In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]- Drug Master File in Korea (Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]- KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]-. The MFDS reviews the Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]- KDMF as part of the drug registration process and uses the information provided in the Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]- KDMF to evaluate the safety and efficacy of the drug.
After submitting a Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]- KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]- API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Acetamide, 2-[(R)-(diphenylmethyl)sulfinyl]- suppliers with KDMF on PharmaCompass.